참고문헌
- Al-Sarraf M, Leblanc M, Giri PG, et al (1998). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol, 16, 1310-7. https://doi.org/10.1200/JCO.1998.16.4.1310
- Chan AT, Teo PM, Johnson PJ (2002). Nasopharyngeal carcinoma. Ann Oncol, 13, 1007-15. https://doi.org/10.1093/annonc/mdf179
- Chen L, Hu CS, Chen XZ, et al (2012). Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. Lancet Oncol, 13, 163-71. https://doi.org/10.1016/S1470-2045(11)70320-5
- Chen L (2009). Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china, 71, 1356-64.
- Chen Y, Liang ZB, Wang SY, et al (2010). A clinical study of acute toxicities of concurrent chemoradiotherapy plus adjuvant chemotherapy in patients with locoregionally advanced carcinoma. Chin Pract Med, 5, 29-31. https://doi.org/10.1186/1749-8546-5-29
- Chi KH, Chang YC, Guo WY, et al (2002). A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys, 52, 1238-44. https://doi.org/10.1016/S0360-3016(01)02781-X
- Ding ZL (2011). Clinical analyses about the adverse reaction in the trial of combination with concurrent chemoradiotherapy and adjuvant chemotherapy for local regionally advanced nasopharyngeal carcinoma. Clin Med, 31, 82-3.
- Fong KW, Chua EJ, Chua ET, et al (1996). Patient profile and survival in 270 computer tomography-staged patients with nasopharyngeal cancer treated at the Singapore General Hospital. Ann Acad Med Singapore, 25, 341-6.
- Heng DM, Wee J, Fong KW, et al (1999). Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer, 86, 1912-20. https://doi.org/10.1002/(SICI)1097-0142(19991115)86:10<1912::AID-CNCR6>3.0.CO;2-S
- Huang HC, Xu HY, Wu SX (2012). Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. Jilin Med J, 33, 2037-40.
- Jpt H, S G (2011). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The cochrane collaboration, available from www.cochranehandbook.org.
- Kwong DL, Sham JS, Au GK, et al (2004). Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol, 22, 2643-53. https://doi.org/10.1200/JCO.2004.05.173
- Kwong DL, Sham JS, Au GK (2006). Five-year update on a randomized factorial study on concurrent and adjuvant chemotherapy for advanced nasopharyngeal carcinoma. Int J Radiat Oncol, 66, S15-6.
- Kwong DL, Sham JS, Au GK, et al (2008). Long-term results of concurrent and adjuvant chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol, 26, 6056. https://doi.org/10.1200/jco.2008.26.15_suppl.6056
- Liang SB (2008). A multicenter prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy to concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma [master].
- Li YH, Wang FH, Jiang WQ, et al (2008). Phase II study of capecitabine and cisplatin combination as firstline chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma. Cancer Chemoth Pharm, 62, 539-44. https://doi.org/10.1007/s00280-007-0641-2
- Ma BB, Chan AT (2005). Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer, 103, 22-31. https://doi.org/10.1002/cncr.20768
- Rossi A, Molinari R, Boracchi P, et al (1988). Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol, 6, 1401-10. https://doi.org/10.1200/JCO.1988.6.9.1401
- Teo P, Yu P, Lee WY, et al (1996). Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys, 36, 291-304.
- Thephamongkhol K, Browman G, Wang R, et al (2004). Chemoradiotherapy versus radiotherapy alone for nasopharyngeal carcinoma: A meta-analysis of 78 randomized controlled trials (RCTs) from English and non-English databases. Proc Am Soc Clin Oncol, 23, 491.
- Wen H, Lang JY, Li ZL (2007). A Prospective study on concurrent conventional Chemoradiotherapy Plus Adjuvant Chemotherapy in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma. Sixth Acad Confer Nat Rad Oncol, 80.
- Xu TT (2008). Prospective randomized clinical trial of combination with concurrent chemoradiotherapy and adjuvant chemotherapy for local regionally advanced nasopharyngeal carcinoma [master].
- Xu TT, Hu CS, Wang XS, et al (2011). Comparing treatment outcomes of different chemotherapy sequences during radiochemotherapy for stage N3 nasopharyngeal carcinoma. Chin J Radiat Oncol, 20, 181-5.
- Yu HS, Wang X, Song AQ, et al (2012). Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Locoregionally Advanced Nasopharyngeal Carcinoma. Asian Pac J Cancer Prev, 13, 3961-5. https://doi.org/10.7314/APJCP.2012.13.8.3961
- Zeng XT, Leng W, Li S, et al (2011). How to Understand and Use GRADE System Correctly? A Briefly Outline. Chin J Evid-Based Med, 11, 985-90.
- Zhang L, Zhao C, Ghimire B, et al (2010). The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials. BMC Cancer, 10, 558. https://doi.org/10.1186/1471-2407-10-558
피인용 문헌
- Optimale Behandlung des Nasopharynxkarzinoms vol.17, pp.8, 2014, https://doi.org/10.1007/s15004-014-0797-y
- The long-term outcomes of alternating chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multiinstitutional phase II study vol.4, pp.8, 2015, https://doi.org/10.1002/cam4.469
- The efficacy and toxicities of intensive induction chemotherapy followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with N3 disease vol.7, pp.1, 2017, https://doi.org/10.1038/s41598-017-03963-8